TY - BOOK AU - Barnett, Christopher F AU - Hofmeyer, Mark AU - Kadakkal, Ajay AU - Medvedofsky, Diego AU - Molina, Ezequiel J AU - Najjar, Samer S AU - Rodrigo, Maria AU - Sawalha, Yazan AU - Sheikh, Farooq AU - Zaghlol, Raja TI - VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication SN - 1434-7229 PY - 2021/// KW - *Heart Failure KW - *Heart-Assist Devices KW - *Ventricular Dysfunction, Right KW - Exercise Test KW - Heart Failure/di [Diagnosis] KW - Humans KW - Oxygen Consumption KW - Prognosis KW - MedStar Heart & Vascular Institute KW - MedStar Washington Hospital Center KW - Internal Medicine Residency KW - Medicine/General Internal Medicine KW - Journal Article N2 - Preoperative cardiopulmonary exercise testing (CPET) is well validated for prognostication before advanced surgical heart failure therapies, but its role in prognostication after LVAD surgery has never been studied. VE/VCO2 slope is an important component of CPET which has direct pathophysiologic links to right ventricular (RV) performance. We hypothesized that VE/VCO2 slope would prognosticate RV dysfunction after LVAD. All CPET studies from a single institution were collected between September 2009 and February 2019. Patients who ultimately underwent LVAD implantation were selectively analyzed. Peak VO2 and VE/VCO2 slope were measured for all patients. We evaluated their association with hemodynamic, echocardiographic and clinical markers of RV dysfunction as well mortality. Patients were stratified into those with a ventilatory class of III or greater. (VE/VCO2 slope of >= 36, n = 43) and those with a VE/VCO2 slope < 36 (n = 27). We compared the mortality between the 2 groups, as well as the hemodynamic, echocardiographic and clinical markers of RV dysfunction. 570 patients underwent CPET testing. 145 patients were ultimately referred to the advanced heart failure program and 70 patients later received LVAD implantation. Patients with VE/VCO2 slope of >= 36 had higher mortality (30.2% vs. 7.4%, p = 0.02) than patients with VE/VCO2 slope < 36 (n = 27). They also had a higher incidence of clinically important RVF (Acute severe 9.3% vs. 0%, Severe 32.6% vs 25.9%, p = 0.03). Patients with a VE/VCO2 slope >= 36 had a higher CVP than those with a lower VE/VCO2 slope (11.2 +/- 6.1 vs. 6.0 +/- 4.8 mmHg, p = 0.007), and were more likely to have a RA/PCWP >= 0.63 (65% vs. 19%, p = 0.008) and a PAPI <= 2 (57% vs. 13%, p = 0.008). In contrast, peak VO2 < 12 ml/kg/min was not associated with postoperative RV dysfunction or mortality. Elevated preoperative VE/VCO2 slope is a predictor of postoperative mortality, and is associated with postoperative clinical and hemodynamic markers of impaired RV performance UR - https://dx.doi.org/10.1007/s10047-021-01261-9 ER -